Funding-round

Garuda Therapeutics - Series A

CompanyGaruda Therapeutics
Amount$50,000,000
CurrencyUSD
Announcement date2025-03-04
Round typeSeries A
Primary source urlhttps://www.finsmes.com/2025/03/garuda-therapeutics-closes-50m-series-a-1-financing.html

Participating investors

CompanyLead
CEO Avanish VellankiLead
Garuda develops proprietary hematopoietic stem cell therapies that enable self-renewingLead
HLA compatibleLead
transgene-free HSCsLead
available immediately for patientsLead